Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-096678
Filing Date
2025-10-03
Accepted
2025-10-03 16:23:25
Documents
1
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2527887-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2527887-2_4seq1.xml 4 6846
  Complete submission text file 0001104659-25-096678.txt   8523
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ALTIMMUNE, INC. 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
Arbet-Engels Christophe (Reporting) CIK: 0001802615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 251374226